open clinical evaluation of siddha medicine kaarasooda sathu parpam for the managemen of azhalneerchurukku (Urinary Tract Infection)

Phase 2

Not yet recruiting

• Conditions: Urinary tract infection, site notspecified,

• Registration Number: CTRI/2023/10/058378
• Lead Sponsor: DR R MURUGALAKSHMI

Brief Summary

This is a phase II Non- Randomized open clinical trial to evaluate the safety and efficacy of siddha medicine Kaara sooda sathu parpam for Azhal Neerchurukku (Urinary tract Infection). The Trial drug Kaarasooda sathu parpam will be prepared as mentioned in the book Sikitcha rathna deepam part-2 and will be given as 500 mg twice a day with honey for 15 days.During the trial all the study related data will be recorded and documented. After the completion of trial all the data will be analysed statistically.

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2023-01-10
• Study Start: 2023-10-15

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

• Age: 20- 60 years Sex: Both Patient having symptoms such as Frequency of micturition Burning micturition Dysuria Lower abdominal pain Low backache / supra pubic pain.
• Hematuria Patient with moderate and severe scoring according to UTI symptom assessment scale i.e., ( > 8 ≤ 21) Patients with Urine culture significant for bacteria or fungus (eg.
• Escherichia coli, klebsiella, enterococci, proteus mirablis staphylococci etc.....).

Exclusion Criteria

Pregnancy H/O Sexually transmitted disease H/O Malignancy H/O Diabetesmellitus Will be excluded clinically or based on the available medical reports.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
It is mainly assessed by reduction in clinical signs and symptoms by UTI symptom assessment score and also assessed by urine culture when bacterial/fungal infection becomes negative after treatment	within 15 days

Secondary Outcome Measures

Name	Time	Method
By comparing the clinical signs and symptoms and the urine culture before and after the treatment 15 days	15 days

Trial Locations

Locations (1)

Arignar anna govt hospital of indian medicine and homeopathy attached with GSMC; 🇮🇳 Chennai, TAMIL NADU, India

Arignar anna govt hospital of indian medicine and homeopathy attached with GSMC

🇮🇳Chennai, TAMIL NADU, India

DR R Murugalakshmi

Principal investigator

9445429052

89murugalakshmi@gmail.com